• Skip to primary navigation
  • Skip to main content
  • Skip to footer
ElevateBio

ElevateBio

Powering the creation of cell & gene therapies at a speed the world deserves.

  • Resources
    • Resources Overview
    • Elevated Insights
    • Presentations & Publications
    • Whitepapers
  • Media
    • Media Overview
    • Press Releases
    • Featured News
  • Facilities
  • Careers
  • Contact
  • Search
  • Manufacturing & Discovery Services
    • Manufacturing & Discovery Services Overview
    • Gene Editing Design & Optimization
    • Process Development
    • Analytical Development
    • cGMP Manufacturing
    • Next-Generation Sequencing
    • Quality
    • Regulatory CMC
    • Certifications & Compliance
    • Generative AI
  • Technologies
    • Technologies Overview
    • Gene Editing
    • Viral and Non-Viral Delivery
    • Messenger RNA (mRNA)
    • Induced Pluripotent Stem Cells (iPSCs)
  • Advanced Therapies
  • Partner With Us
  • About
    • About Overview
    • Our Journey
    • Our Team
    • Culture of Expedition
    • Careers
  • Media
    • Investors & Media Overview
    • Press Releases
    • Presentations & Publications
    • Elevated Insights
  • Careers
  • Facilities
  • Contact
  • Manufacturing & Discovery Services

    Manufacturing & Discovery Services Overview

    Capabilities & Services
    • Gene Editing Design & Optimization
    • Process Development
    • Analytical Development
    • cGMP Manufacturing
    • Next-Generation Sequencing
    Expertise
    • Quality
    • Regulatory CMC
    • Certifications & Compliance
    • Generative AI
  • Technologies
    • Technologies Overview
    • Gene Editing
    • Viral and Non-Viral Delivery
    • Messenger RNA (mRNA)
    • Induced Pluripotent Stem Cells (iPSCs)
  • Advanced Therapies
  • Partner With Us
  • About
    • About Overview
    • Our Journey
    • Our Team
    • Culture of Expedition
    • Careers
    • Investors

Presentations & Publications

// Feb 10, 2026 | Presentation

Advanced Therapies Week 2026

Reducing Turnaround Time and Cost in Cell Therapy Manufacturing Through Integrated At-Line Immunophenotyping QC

View Presentation

// Feb 10, 2026 | Presentation

Advanced Therapies Week 2026

Automating Cell Therapy: A Closed, Digital Platform Delivers Consistent, Sterile, Scalable T‑Cell Production

View Presentation

// Feb 10, 2026 | Presentation

Advanced Therapies Week 2026

Evaluating the Automated Accellix® Platform against Conventional Flow Cytometry for Cell Therapy Samples

View Presentation

// Feb 10, 2026 | Presentation

Advanced Therapies Week 2026

Supporting Therapy Platform Development with Advanced Characterization of Engineered T Cells via Single-cell Sequencing and Flow Cytometry

View Presentation

// Feb 07, 2026 | Presentation

Society for Laboratory Automation and Screening Conference 2026

Precision at any input: High-throughput automated workflow ensures uniform gene expression profiles across broad RNA inputs

View Presentation

// Jan 23, 2026 | Presentation

7th International Conference on Base Editing, Prime Editing & Related Enzymes (Deaminet 2026)

Building a differentiated portfolio of base editors for therapeutic applications

View Presentation

// Jan 22, 2026 | Presentation

7th International Conference on Base Editing, Prime Editing & Related Enzymes (Deaminet 2026)

Engineering potency and specificity of base editors towards genomic medicine

View Presentation

// Oct 07, 2025 | Presentation

2025 Cell & Gene Meeting on the Mesa

Rapid Analytics and Next Generation Sequencing

View Presentation

// Oct 06, 2025 | Presentation

2025 Cell & Gene Meeting on the Mesa

ElevateBio BaseCamp – Delivering Genetic Medicines From Concept Through Commercialization

View Presentation

// Oct 06, 2025 | Presentation

2025 Cell & Gene Meeting on the Mesa

ElevateBio Life Edit – Opening New Frontiers in Genomic Medicine

View Presentation

// Sep 24, 2025 | Presentation

CAR-TCR Summit

Successfully Implementing Lean Manufacturing for Late Phase and Commercial CGT

View Presentation

// Sep 24, 2025 | Presentation

CAR-TCR Summit

Non-Viral TCR Knock-In Using LEG14 Nuclease and HDR Templates for T-Cell Engineering

View Presentation

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 6
  • Next

Footer

ElevateBio

Investors & Media

LinkedIn Twitter

© 2026 ElevateBio. All Rights Reserved.

Privacy & Cookie Policy

  • Manufacturing & Discovery Services
  • Technologies
  • Advanced Therapies
  • Partner With Us
  • About
  • Presentations & Publications
  • Elevated Insights
  • Careers
  • Facilities
  • Contact
MENU
  • Manufacturing & Discovery Services
    • Manufacturing & Discovery Services Overview
    • Gene Editing Design & Optimization
    • Process Development
    • Analytical Development
    • cGMP Manufacturing
    • Next-Generation Sequencing
    • Quality
    • Regulatory CMC
    • Certifications & Compliance
    • Generative AI
  • Technologies
    • Technologies Overview
    • Gene Editing
    • Viral and Non-Viral Delivery
    • Messenger RNA (mRNA)
    • Induced Pluripotent Stem Cells (iPSCs)
  • Advanced Therapies
  • Partner With Us
  • About
    • About Overview
    • Our Journey
    • Our Team
    • Culture of Expedition
    • Careers
  • Media
    • Investors & Media Overview
    • Press Releases
    • Presentations & Publications
    • Elevated Insights
  • Careers
  • Facilities
  • Contact